Sareum secures Japan patent for kinase inhibitor asset : com

Biotechnology firm Sareum announced on Friday that it has received a notice of allowance from the Japan Patent Office for a patent associated with SDC-1801, its primary TYK2/JAK1 kinase inhibitor.

Related Keywords

Australia , Japan , United States , Japanese , , Japan Patent Office , Sareum Holdings , China National Intellectual Property Administration , Special Application , Sareum , Secures , Patent , Kinase , Inhibitor , Asset , Category All , Category Market Report , Category Company News , Category News And Announcements , Category Small Caps News , Category Aim Bulletin , Category Tecnologia , Category Market Pulse , Category Sectorial Process Industries , Mostread Technology , Mostread Small Caps , Mostread Company News ,